Ohio Public Employees Retirement System (OPERS)’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-26,832
Closed -$562K 2367
2026
Q1
$562K Sell
26,832
-915
-3% -$20.6K ﹤0.01% 1448
2025
Q4
$638K Sell
27,747
-312
-1% -$10.3K ﹤0.01% 1445
2025
Q3
$844K Buy
28,059
+174
+0.6% +$5.22K ﹤0.01% 1392
2025
Q2
$1.01M Buy
27,885
+543
+2% +$19.6K ﹤0.01% 1335
2025
Q1
$990K Sell
27,342
-3,163
-10% -$132K ﹤0.01% 1315
2024
Q4
$1.28M Sell
30,505
-2,229
-7% -$111K ﹤0.01% 1282
2024
Q3
$1.82M Sell
32,734
-538
-2% -$27.4K 0.01% 1096
2024
Q2
$1.37M Buy
33,272
+3,198
+11% +$137K 0.01% 1083
2024
Q1
$1.4M Sell
30,074
-2,836
-9% -$134K 0.01% 1060
2023
Q4
$1.57M Buy
32,910
+5,359
+19% +$208K 0.01% 1060
2023
Q3
$982K Sell
27,551
-3,051
-10% -$121K ﹤0.01% 1132
2023
Q2
$1.41M Sell
30,602
-24,743
-45% -$1.15M 0.01% 1092
2023
Q1
$2.22M Sell
55,345
-1,031
-2% -$44.2K 0.01% 961
2022
Q4
$2.61M Buy
56,376
+18,525
+49% +$729K 0.01% 907
2022
Q3
$1.57M Buy
37,851
+4,604
+14% +$237K 0.01% 1113
2022
Q2
$1.98M Sell
33,247
-2,776
-8% -$171K 0.01% 1067
2022
Q1
$2.62M Sell
36,023
-1,229
-3% -$85.5K 0.01% 1019
2021
Q4
$3.13M Sell
37,252
-734
-2% -$59.7K 0.01% 952
2021
Q3
$3.43M Sell
37,986
-290
-0.8% -$26.2K 0.01% 930
2021
Q2
$3.65M Buy
38,276
+37,066
+3,063% +$3.86M 0.01% 909
2021
Q1
$138K Hold
1,210
﹤0.01% 1581
2020
Q4
$168K Sell
1,210
-158
-12% -$18.7K ﹤0.01% 1462
2020
Q3
$112K Buy
+1,368
New +$113K ﹤0.01% 1475

Other funds holding RARE

Ohio Public Employees Retirement System (OPERS)'s RARE Position: Q2 2026 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Ultragenyx Pharmaceutical (RARE) in Q2 2026, closing a stake of 26,832 shares — an estimated $562K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in RARE in Q3 2020 and held it in 23 quarters. The position peaked at $3.65M in Q2 2021. 310 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Ultragenyx Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 26,832 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $562K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Ultragenyx Pharmaceutical in Q3 2020 and held it in 23 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Ultragenyx Pharmaceutical position peaked at $3.65M in Q2 2021.
  • 310 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2026, filed 17 Aug 2026.